tremelimumab,durvalumab
astrazeneca
['himalaya', 'topaz1']
its being a very exiting week for hepato-biliary! first #topaz1 and now #himalaya! and all while #asco22 is still ongoing. 
Consultant in Medical Oncology with expertise in HPB and Neuroendocrine Tumours. Fundación Jiménez Díaz University Hospital. #BiliaryTractTumor #NET